Cargando…

Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination

Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease and has occasionally been described after vaccination, especially against viral agents. We present a case of a patient who presents with the classic pentad of TTP a few days after receiving the first dose of the mRNA Pfizer COVID‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Alislambouli, Mawaddah, Veras Victoria, Andy, Matta, Jyoti, Yin, Faye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657522/
https://www.ncbi.nlm.nih.gov/pubmed/34909764
http://dx.doi.org/10.1002/jha2.342
_version_ 1784612521783590912
author Alislambouli, Mawaddah
Veras Victoria, Andy
Matta, Jyoti
Yin, Faye
author_facet Alislambouli, Mawaddah
Veras Victoria, Andy
Matta, Jyoti
Yin, Faye
author_sort Alislambouli, Mawaddah
collection PubMed
description Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease and has occasionally been described after vaccination, especially against viral agents. We present a case of a patient who presents with the classic pentad of TTP a few days after receiving the first dose of the mRNA Pfizer COVID‐19 vaccine. To our knowledge, this is the second report of a de novo TTP following mRNA Pfizer COVID‐19 vaccination.
format Online
Article
Text
id pubmed-8657522
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-86575222021-12-10 Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination Alislambouli, Mawaddah Veras Victoria, Andy Matta, Jyoti Yin, Faye EJHaem Case Reports Acquired thrombotic thrombocytopenic purpura (aTTP) is a rare disease and has occasionally been described after vaccination, especially against viral agents. We present a case of a patient who presents with the classic pentad of TTP a few days after receiving the first dose of the mRNA Pfizer COVID‐19 vaccine. To our knowledge, this is the second report of a de novo TTP following mRNA Pfizer COVID‐19 vaccination. John Wiley and Sons Inc. 2021-11-16 /pmc/articles/PMC8657522/ /pubmed/34909764 http://dx.doi.org/10.1002/jha2.342 Text en © 2021 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Alislambouli, Mawaddah
Veras Victoria, Andy
Matta, Jyoti
Yin, Faye
Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
title Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
title_full Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
title_fullStr Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
title_full_unstemmed Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
title_short Acquired thrombotic thrombocytopenic purpura following Pfizer COVID‐19 vaccination
title_sort acquired thrombotic thrombocytopenic purpura following pfizer covid‐19 vaccination
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657522/
https://www.ncbi.nlm.nih.gov/pubmed/34909764
http://dx.doi.org/10.1002/jha2.342
work_keys_str_mv AT alislamboulimawaddah acquiredthromboticthrombocytopenicpurpurafollowingpfizercovid19vaccination
AT verasvictoriaandy acquiredthromboticthrombocytopenicpurpurafollowingpfizercovid19vaccination
AT mattajyoti acquiredthromboticthrombocytopenicpurpurafollowingpfizercovid19vaccination
AT yinfaye acquiredthromboticthrombocytopenicpurpurafollowingpfizercovid19vaccination